PMC7518023_01
The simulated pharmacokinetics profile with 95% confidence intervals after giving the high-dose meropenem.
fphar-11-566060-g001.jpg
PMC7518023_01_fphar-11-566060-g001.jpg
f1
The simulated pharmacokinetics profile with 95% confidence intervals after giving the high-dose regimen is presented in  Figure 1 .
Clinical course of the premature neonate with CRE infection. PCT, procalcitonin; CRP, C-reactive protein; WBC, white blood cell count; PLT, platelet.
fphar-11-566060-g002.jpg
PMC7518023_01_fphar-11-566060-g002.jpg
f2
Subsequently, with the treatment of high-dose meropenem, the condition of the baby improved with normalization of PCT, CRP, WBC, and PLT levels ( Figure 2 ) and negative blood culture.